These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3991493)

  • 1. Effect of eosinophilia on the heterogeneity of the anticoagulant response to heparin in haemodialysis patients.
    Santoro A; Zucchelli P; Trombetti E; Degli Esposti E; Sturani A; Zuccalà A; Chiarini C; Casadei-Maldini M; Mazzuca A
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():143-9. PubMed ID: 3991493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to heparin anticoagulant response in eosinophilic patients.
    Santoro A; Ferrari G; Zucchelli P
    Kidney Int Suppl; 1988 Mar; 24():S84-5. PubMed ID: 3163060
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
    Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin elimination in uraemic patients on Haemodialysis.
    Teien AN; Bjoornson J
    Scand J Haematol; 1976 Jul; 17(1):29-35. PubMed ID: 959771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: anticoagulation for haemodialysis.
    Suranyi M; Chow JS
    Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR
    Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III and heparinemia in patients on hemodialysis].
    Nagami AE; Sesin AM; Nattero GN
    Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
    [No Abstract]   [Full Text] [Related]  

  • 12. The heterogeneity of the anticoagulant response to heparin.
    Estes JW
    J Clin Pathol; 1972 Jan; 25(1):45-8. PubMed ID: 5015373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of factors related to hemodialysis on certain blood-coagulation parameters].
    Koslik S; Moscovic F; Matejícková G
    Z Urol Nephrol; 1978 May; 71(5):339-44. PubMed ID: 676538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and anticoagulant effect of 51Cr-labelled heparin.
    Alánt O; Varga L; Antoni F; Karácsonyi S; Faller J
    Acta Physiol Acad Sci Hung; 1973; 43(3):261-7. PubMed ID: 4790805
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of vitamin E-bonded dialyzer on eosinophilia in haemodialysis patients.
    Kojima K; Oda K; Homma H; Takahashi K; Kanda Y; Inokami T; Uchida S
    Nephrol Dial Transplant; 2005 Sep; 20(9):1932-5. PubMed ID: 15919688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heparin-free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment.
    Matsui N; Nakamura Y; Shinoda T; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Proc Eur Dial Transplant Assoc; 1980; 17():253-8. PubMed ID: 7243776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis and heparin.
    Thayssen P; Pindborg T
    Scand J Urol Nephrol; 1978; 12(1):73-4. PubMed ID: 345433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
    Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.